Category: ‘Research for a Cure’
Posted on February 1st, 2024
After three months of home-based rehabilitation training with the brain-machine interface, the patient was able to control a pneumatic glove through brain activity.
Just as Elon Musk’s Neuralink announced their success in putting an implant into a human brain, making headlines globally, China also showcases its latest progress in clinical application of brain-computer interfaces (BCIs), highlighting another emerging area of fierce competition between these 2 powers.
Posted on January 8th, 2024
Grégoire Courtine, Jocelyne Bloch and their research team have been breaking new ground in the treatment of neurological disorders for over a decade. Here’s a look at some of the promising new therapies they’ve developed.
Posted on November 27th, 2023
A device designed by Johns Hopkins researchers may hold promise for restoring mobility to those with lower limb paralysis.
A Johns Hopkins materials scientist and collaborators have developed a tiny device that may hold promise for restoring mobility to those with lower limb paralysis, a condition affecting approximately 1.4 million Americans.
Posted on September 23rd, 2023
Scientists at the NeuroRestore Centre in Switzerland have developed a gene therapy that was proven to stimulate nerve regrowth across complete spinal cord injuries in mice.
A complete spinal cord injury leads to irreversible paralysis. To combat this, the scientists’ gene therapy guides nerves to reconnect to their natural targets below the injuries in order to restore motor function.
Posted on September 21st, 2023
Guiding cells to natural target region key to functional recovery
In a new study in mice, a team of researchers from UCLA, the Swiss Federal Institute of Technology, and Harvard University have uncovered a crucial component for restoring functional activity after spinal cord injury. The neuroscientists have shown that re-growing specific neurons back to their natural target regions led to recovery, while random regrowth was not effective.